Attached files
file | filename |
---|---|
EX-99.1 - EXHIBIT 99.1 - MEDCO HEALTH SOLUTIONS INC | c12999exv99w1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 22, 2011
MEDCO HEALTH SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
Delaware | 1-31312 | 22-3461740 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
100 Parsons Pond Drive, Franklin Lakes, NJ |
07417 |
|
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: 201-269-3400
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition.
On
February 22, 2011, Medco Health Solutions, Inc. (the Company) issued a press release
reporting the financial results for its fiscal year ended December 25, 2010. A copy of the press
release is attached to this Current Report on Form 8-K (Current Report) as Exhibit 99.1 and is
incorporated herein solely for purposes of this Item 2.02 disclosure.
The information in Item 2.02 of this Current Report, including Exhibit 99.1 attached hereto,
is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section. The
information in Item 2.02 of this Current Report, including Exhibit 99.1 attached hereto, shall not
be incorporated by reference into any registration statement or other document pursuant to the
Securities Act of 1933, as amended.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. | Description | |||
99.1 | Press Release dated February 22, 2011 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDCO HEALTH SOLUTIONS, INC. |
||||
Date: February 22, 2011 | By: | /s/ Thomas M. Moriarty | ||
Thomas M. Moriarty | ||||
General Counsel, Secretary and Senior Vice President, Pharmaceutical Strategies and Solutions |
EXHIBIT INDEX
Exhibit No. | Description | |||
99.1 | Press Release dated February 22, 2011 |